Courtesy of Benzinga.
Credit Suisse upgraded Laboratory Corp. of America Holdings (NYSE: LH) from Neutral to Outperform.
The price target for Laboratory of America has been raised from $113.00 to $140.00.
Laboratory of America shares have gained 29.14% over the past 52 weeks, while the S&P 500 index has surged 14.22% in the same period.
Laboratory of America’s shares rose 3.36% to close at $121.08 on Friday.
Latest Ratings for LH
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2015 | Piper Jaffray | Upgrades | Neutral | Overweight |
Feb 2015 | Credit Suisse | Upgrades | Neutral | Outperform |
Feb 2015 | UBS | Downgrades | Buy | Neutral |
View More Analyst Ratings for LH
View the Latest Analyst Ratings
Posted-In: Credit SuisseUpgrades Analyst Ratings